Loading cancer entity…
Loading cancer entity…
Clinical trials
3,221 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (571)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03384836 | Propranolol Hydrochloride and Pembrolizumab in Treating Patients With Stage IIIC-IV Melanoma That Cannot Be Removed by Surgery | suspended | Phase 1 / Phase 2 | 47 | Roswell Park Cancer InstituteOTHER | 1 | Jul 15, 2026 | clinicaltrials |
| NCT05756556 | T3011 in Combination With Cobimetinib in Patients With Advanced Melanoma | suspended | Phase 2 | 68 | ImmVira Pharma Co. LtdINDUSTRY | 1 | Feb 1, 2024 | clinicaltrials |
| NCT04427306 | Neoadjuvant T-VEC in High Risk Early Melanoma | suspended | Phase 2 | 6 | University of California, DavisOTHER | 1 | Sep 15, 2023 | clinicaltrials |
| NCT01988831 | Efficacy of Propranolol Treatment to Prevent Melanoma Progression | suspended | Phase 2 | 450 | University Hospital, GenevaOTHER | 1 | May 10, 2019 | clinicaltrials |
| NCT00278122 | Paclitaxel and GM-CSF in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery | suspended | Phase 2 | 42 | University of VirginiaOTHER | 1 | Dec 10, 2013 | clinicaltrials |
| NCT00042497 | Immunotherapy With Autologous Dexosomes for Patients With Stage IV Melanoma | suspended | Phase 2 | 60 | AnosysINDUSTRY | 0 | Jun 24, 2005 | clinicaltrials |
Data updated 22 days agoSource updated Jul 15, 2026source: clinicaltrials